Table 6.
Malignancy | White n (%) | Black n (%) | Other n (%) | χ2 (df) | p |
---|---|---|---|---|---|
ALL | 55 (20.52) | 12 (10.00) | 21 (24.14) | 8.30 (2) | 0.016 |
CNS/Brain | 45 (16.79) | 25 (20.83) | 15 (17.24) | 0.953 (2) | 0.621 |
Renal | 15 (5.60) | 12 (10.00) | 5 (5.75) | 2.72 (2) | 0.256 |
Endocrine Gland | 17 (6.34) | 10 (8.33) | 4 (4.60) | 1.19 (2) | 0.552 |
Lymphoma | 18 (6.72) | 5 (4.17) | 7 (8.05) | 1.45 (2) | 0.484 |
Osteosarcoma | 17 (6.34) | 9 (7.50) | 3 (3.45) | 1.50 (2) | 0.471 |
AML | 14 (5.22) | 9 (7.5) | 5 (5.75) | 0.778 (2) | 0.678 |
Connective Tissue | 15 (5.60) | 7 (5.83) | 5 (5.75) | 0.0094 (2) | 0.995 |
Notes and abbreviations: Percentages do not sum to 100% since we only examined the 8 most diagnosed malignancies; ALL: Acute lymphoblastic leukemia; CNS: Central Nervous System; AML: Acute myeloid leukemia; χ2 (df): chi-square statistic, degrees freedom; p: probability value.